Literature DB >> 9799893

Cardiac syncope due to transient coronary artery occlusion: the role of percutaneous angioplasty.

S Burn1, R Schilling, G C Kaye.   

Abstract

A case of cardiac syncope is presented, associated with single vessel coronary disease. The mechanism of the syncope would appear to be a ventricular arrhythmia with transmural myocardial ischaemia due to transient occlusion of the diseased coronary artery. The symptoms and electrocardiographic abnormalities were reproduced and subsequently abolished by percutaneous coronary angioplasty.

Entities:  

Mesh：

Year:  1998        PMID： 9799893      PMCID： PMC2360952          DOI： 10.1136/pgmj.74.872.361

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  6 in total

1.  Successful treatment of complex ventricular arrhythmias with percutaneous transluminal coronary angioplasty.

Authors:  T C Hilton; F Aguirre; T Greenwalt; D L Janosik; M J Kern
Journal:  Am Heart J       Date:  1991-07       Impact factor: 4.749

2.  Surgical treatment of ventricular irritability.

Authors:  E D Mundth; M J Buckley; R W DeSanctis; W M Daggett; W G Austen
Journal:  J Thorac Cardiovasc Surg       Date:  1973-12       Impact factor: 5.209

3.  Clinical characteristics associated with sudden death in patients with variant angina.

Authors:  D D Miller; D D Waters; J Szlachcic; P Théroux
Journal:  Circulation       Date:  1982-09       Impact factor: 29.690

4.  Angina pectoris. I. A variant form of angina pectoris; preliminary report.

Authors:  M PRINZMETAL; R KENNAMER; R MERLISS; T WADA; N BOR
Journal:  Am J Med       Date:  1959-09       Impact factor: 4.965

5.  Effect of percutaneous transluminal coronary angioplasty on arrhythmias complicating angina.

Authors:  A O Molajo; G D Summers; D H Bennett
Journal:  Br Heart J       Date:  1985-10

6.  Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise-induced ischaemia.

Authors:  R F Berntsen; P Gunnes; M Lie; K Rasmussen
Journal:  Eur Heart J       Date:  1993-10       Impact factor: 29.983
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.